266 related articles for article (PubMed ID: 22576324)
1. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
Hulskotte E; Gupta S; Xuan F; van Zutven M; O'Mara E; Feng HP; Wagner J; Butterton J
Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
[TBL] [Abstract][Full Text] [Related]
2. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
Garg V; van Heeswijk R; Lee JE; Alves K; Nadkarni P; Luo X
Hepatology; 2011 Jul; 54(1):20-7. PubMed ID: 21618566
[TBL] [Abstract][Full Text] [Related]
3. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
Charlton M
Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
[No Abstract] [Full Text] [Related]
4. Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir.
Hulskotte EG; Feng HP; Xuan F; van Zutven MG; Treitel MA; Hughes EA; O'Mara E; Youngberg SP; Wagner JA; Butterton JR
Clin Infect Dis; 2013 Mar; 56(5):718-26. PubMed ID: 23155151
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
Sansone-Parsons A; Krishna G; Martinho M; Kantesaria B; Gelone S; Mant TG
Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
[TBL] [Abstract][Full Text] [Related]
6. Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole.
de Kanter CT; Colbers AP; Blonk MI; Verweij-van Wissen CP; Schouwenberg BJ; Drenth JP; Burger DM
J Antimicrob Chemother; 2013 Jun; 68(6):1415-22. PubMed ID: 23429642
[TBL] [Abstract][Full Text] [Related]
7. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects.
Bifano M; Adamczyk R; Hwang C; Kandoussi H; Marion A; Bertz RJ
Clin Drug Investig; 2015 May; 35(5):281-9. PubMed ID: 25896946
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.
Hulskotte EG; Bruce RD; Feng HP; Webster LR; Xuan F; Lin WH; O'Mara E; Wagner JA; Butterton JR
Eur J Clin Pharmacol; 2015 Mar; 71(3):303-11. PubMed ID: 25666027
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatin.
Hulskotte EG; Feng HP; Xuan F; Gupta S; van Zutven MG; O'Mara E; Wagner JA; Butterton JR
Antimicrob Agents Chemother; 2013 Jun; 57(6):2582-8. PubMed ID: 23529734
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
Lam H; Jeffery J; Sitar DS; Aoki FY
Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function.
Treitel M; Marbury T; Preston RA; Triantafyllou I; Feely W; O'Mara E; Kasserra C; Gupta S; Hughes EA
Clin Pharmacokinet; 2012 Sep; 51(9):619-28. PubMed ID: 22799589
[TBL] [Abstract][Full Text] [Related]
12. [Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors].
Ruiz Ramos J; Romero Hernández I; Marrero Álvarez P; Marqués Miñana MR; Fernández Megía MJ; Poveda Andrés JL
Gastroenterol Hepatol; 2014 Dec; 37(10):558-63. PubMed ID: 24951300
[TBL] [Abstract][Full Text] [Related]
13. Lack of a clinically significant drug-drug interaction in healthy volunteers between the hepatitis C virus protease inhibitor boceprevir and the HIV integrase inhibitor raltegravir.
de Kanter CT; Blonk MI; Colbers AP; Schouwenberg BJ; Burger DM
Clin Infect Dis; 2013 Jan; 56(2):300-6. PubMed ID: 23001704
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.
Jackson A; D'Avolio A; Moyle G; Bonora S; Di Perri G; Else L; Simiele M; Singh GJ; Back D; Boffito M
J Antimicrob Chemother; 2014 Jul; 69(7):1911-5. PubMed ID: 24610312
[TBL] [Abstract][Full Text] [Related]
15. A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers.
Mora-Peris B; Else L; Goldmeier D; Mears A; Weston R; Cooke G; Khoo S; Back D; Winston A
J Antimicrob Chemother; 2015; 70(6):1812-5. PubMed ID: 25693997
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.
Feng HP; Caro L; Fandozzi CM; Guo Z; Talaty J; Wolford D; Panebianco D; Iwamoto M; Butterton JR; Yeh WW
J Clin Pharmacol; 2018 May; 58(5):666-673. PubMed ID: 29329497
[TBL] [Abstract][Full Text] [Related]
17. Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
Brandhorst G; Tenderich G; Zittermann A; Oezpeker C; Koerfer R; Oellerich M; Armstrong VW
Ther Drug Monit; 2008 Feb; 30(1):113-6. PubMed ID: 18223473
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects.
Kropeit D; von Richter O; Stobernack HP; Rübsamen-Schaeff H; Zimmermann H
Clin Pharmacol Drug Dev; 2018 Jan; 7(1):9-21. PubMed ID: 28967706
[TBL] [Abstract][Full Text] [Related]
19. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
Takeuchi H; Matsuno N; Hirano T; Toraishi T; Konno O; Nakamura Y; Iwamoto H; Hama K; Unezaki S; Nagao T
Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203
[TBL] [Abstract][Full Text] [Related]
20. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction.
Kovarik JM; Schmouder RL; Barilla D; Büche M; Rouilly M; Berthier S; Wang Y; Van Saders C; Mayer T; Gottlieb AB
Ann Pharmacother; 2004; 38(7-8):1153-8. PubMed ID: 15138297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
